HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ruhina Maeshima Selected Research
Ruhina Maeshima Research Topics
Disease
5
Neuroblastoma
09/2021 - 02/2015
4
Neoplasms (Cancer)
01/2022 - 01/2020
1
Cystic Fibrosis (Mucoviscidosis)
04/2024
1
Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
04/2024
1
Genetic Skin Diseases
12/2023
1
Skin Diseases (Skin Disease)
12/2023
1
Melanoma (Melanoma, Malignant)
01/2022
1
Carcinoma (Carcinomatosis)
01/2022
1
Amyloid Plaque
09/2014
Drug/Important Bio-Agent (IBA)
2
Lipid Nanoparticles
IBA
04/2024 - 12/2023
2
Lipids
IBA
01/2022 - 09/2021
2
Small Interfering RNA (siRNA)
IBA
09/2021 - 09/2014
2
Transcription Factors (Transcription Factor)
IBA
09/2021 - 01/2020
2
Tretinoin (Retinoic Acid)
FDA Link
Generic
01/2020 - 01/2020
1
Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)
IBA
04/2024
1
DNA (Deoxyribonucleic Acid)
IBA
12/2023
1
Messenger RNA (mRNA)
IBA
01/2022
1
Peptides (Polypeptides)
IBA
01/2022
1
Cholesterol
IBA
01/2022
1
Polymers
IBA
09/2021
1
arginyl-glycyl-aspartic acid
IBA
09/2021
1
Integrins
IBA
09/2021
1
Ligands
IBA
10/2020
1
Ethanol (Ethyl Alcohol)
IBA
10/2020
1
Liposomes (Liposome)
IBA
10/2020
1
Amines
IBA
10/2020
1
Cytochrome P450 Family 26
IBA
01/2020
1
Retinoids
IBA
01/2020
1
N-Myc Proto-Oncogene Protein
IBA
01/2020
1
bis(maltolato)oxovanadium(IV)
IBA
02/2015
1
Buthionine Sulfoximine
IBA
02/2015
1
Enzymes
IBA
09/2014
Therapy/Procedure
4
Therapeutics
12/2023 - 02/2015
1
Intravenous Administration
09/2021